期刊文献+

人工心脏起搏对血浆NT-proBNP影响的临床研究 被引量:2

下载PDF
导出
摘要 目的探讨血浆NT-proBNP对永久性心脏起搏器植入患者心功能早期诊断、起搏模式选择和心脏起搏后心功能监测的意义。方法入选59例长期心脏起搏患者,比较不同起搏模式下NT-proBNP和LVEF水平的异同,对其中的31例DDD起搏患者,程控为VVI起搏模式1个月后,比较不同NYHA心功能分级患者血浆NT-proBNP和LVEF水平的变化。结果(1)长期起搏患者VVI组血浆NT-proBNP较DDD组为高(P〈0.05)。VVI和DDD起搏患者NT-proBNP与LVEF均呈显著负相关,其相关系数(R)分别为-0.83和-0.64(P〈0.01)。(2)DDD起搏程控为VVI起搏后1个月,NT-proBNP水平在不同心功能分级患者均显著升高(P〈0.01)。LVEF水平仅在心功能Ⅲ~Ⅳ级患者程控为VVI起搏1个月后显著降低(P〈0.01)。结论VVI起搏比DDD起搏更易引起NT-proBNP升高,血浆NT-proBNP能早期敏感评价不同起搏模式对心功能的影响,对选择合适的起搏模式和起搏后随访有重要意义。
出处 《浙江实用医学》 2010年第1期1-2,11,共3页 Zhejiang Practical Medicine
基金 温州市卫生局资助项目(200707)
  • 相关文献

参考文献8

  • 1Pfister R, Scholz M, Wielckensk, et al. Use of NT - proBNP in routing testing and comparison to BNP. Eur J Heart Fail,2004,6(3):287.
  • 2Angelike H, Wilmal, Gerda F. et al. Natriuretic peptidesas markers of mild foms of left ventricular dysfunction: Efects of assayson diagnostic perfomance of markers. Clin Chem, 2004,50(8 ) : 1174.
  • 3史晓敏 徐国宾 夏铁安 等.血清N末端B型钠尿肽原的参考值建立及其在慢性充血性心力衰竭诊断中的应用[J].检验医师杂志,2005,2(3):141-146.
  • 4汪芳,黄洁,庞会敏,边文彦,王莉,明广华,顼志敏,李一石.慢性心力衰竭患者血浆氨基末端脑钠素前体水平对病情的评估[J].临床心血管病杂志,2006,22(7):407-409. 被引量:13
  • 5Hunt P J, Richardsam, Nicholls M G, et al. Immunoreactive aminotenninal probrain natriuretic peptide( NT- proBNP) : a new marker of cardiac impairment. Clin Endocrinol, 1997,47 (3) : 287.
  • 6James S K, Lindahl B, Siegbahn A, et al.N- tenninal pro brain batriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarctian in palients with anstable coronary artery disease: a global utilization of strategies to open occluded arteries (GUSTO) - IV substudy. Circulatian, 2003, 108 (3) :275.
  • 7J' HOlier C, Brandtetal J. Improved cardiac function and quality of life following upgrade to dual chamber pacing after long - term ventricular slimulation. Eur Heart J,2002,23:490.
  • 8Mecheal D, Gammage, Anna- Marie Marsh. Randomized trials for selective sitepacing:do we know where we are going? PACE, 2004, 27 (part2) :878.

二级参考文献10

  • 1汤永谦,张海蓉,王艳,陶红,沈青山,刘文卫,成蓓.心力衰竭患者脑钠素水平与6min步行试验相关性研究[J].临床心血管病杂志,2005,21(10):586-587. 被引量:9
  • 2WIECZOREK S J, WU A H, CHRISTENSON R, et al. A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation[J]. Am Heart J, 2002 ,144:834-839.
  • 3MAISEL A. B-type natriuretic peptide levels: diagnostic and therapeutic potential[J]. Cardiovasc Toxicol , 2001,1:159-164.
  • 4RY S D, CLERICO A, GIANNESSI D, et al. Measurement of brain natriuretic peptide in plasma samples and cardiac tissue extracts by means of an immunoradiometric assay method[J]. Scand J Clin Lab Invest,2000,60:81-90.
  • 5HAMMERER-LERCHER A, NEUBAUER E,MULLER S, et al. Head-to-head comparison of N-terminal pro-BNP,BNP,and Nt-proANP in diagnosing left ventricular dysfunction [J]. Clin Chim Acta,2001,310: 193-197.
  • 6MUELLER T, GEGENHUBER A, POELZ W, et al. Diagnostie aeeuraey of B type natriuretie peptide and amino terminal proBNP in the emergeney diagnosis of heart failure[J]. Heart, 2005,91:606-612.
  • 7YEO K T, WU A H, APPLE F S, et al. Multicenter evaluation of the roche NT-proBNP assay and comparison to the biosite triage BNP assay[J]. Clin Chim Acta, 2003,338:107-115.
  • 8HUNT P J, RICHARDS A M, NICHOLI.S M G, et al. Immunoreactive amino-terminal pro-brain natriuretic peptide: a new marker of cardiac impairment[J]. Clin Endocrinol, 1997, 47: 287-296.
  • 9HOBBS F D, DAVIS R C, ROALFE A K, et al. Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations [J].BMJ, 2002, 324: 1498-1504.
  • 10任兵,胡盛寿,朱晓东,李国荣,马维国,张红叶,孙凯,公茂莲.肾素-血管紧张素系统各指标的测定及其正常值[J].标记免疫分析与临床,2002,9(3):181-182. 被引量:5

共引文献13

同被引文献12

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部